These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 2572058)

  • 41. [The interaction potential of H2 receptor antagonists. A short current review].
    Klotz U; Kroemer HK
    Fortschr Med; 1991 Sep; 109(28):574-6. PubMed ID: 1684557
    [No Abstract]   [Full Text] [Related]  

  • 42. [Current aspects of course treatment and secondary prevention of peptic ulcer].
    Ryss ES
    Klin Med (Mosk); 1990 Apr; 68(4):134-42. PubMed ID: 1973467
    [No Abstract]   [Full Text] [Related]  

  • 43. Directives, methods and suggestions for anti-ulcer drug therapy.
    Varró V
    Ther Hung; 1985; 33(3):125-31. PubMed ID: 2876535
    [No Abstract]   [Full Text] [Related]  

  • 44. Asymptomatic peptic ulcer disease. Is it worth looking for?
    Corinaldesi R; De Giorgio R; Paternicò A; Stanghellini V
    Drugs; 1991 Jun; 41(6):821-4. PubMed ID: 1715260
    [No Abstract]   [Full Text] [Related]  

  • 45. [Gastroduodenal ulcers].
    Lémann M
    Rev Infirm; 1988 Oct; 38(15):43-6. PubMed ID: 2905071
    [No Abstract]   [Full Text] [Related]  

  • 46. The limitations of current therapy in peptic ulcer disease.
    Salena BJ; Hunt RH
    Clin Invest Med; 1987 May; 10(3):171-7. PubMed ID: 3304747
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Clinical, secretory, radiological and endoscopic evolution of patients with gastroduodenal ulcer treated with Ulcosilvanil, as compared with those treated with histamine H2 receptor antagonists].
    Contraşiu P; Calinici V
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1980; 32(4):359-63. PubMed ID: 6113650
    [No Abstract]   [Full Text] [Related]  

  • 48. [Pharmacologic treatment of ulcers].
    Honorato Pérez J; Azanza Perea JR; Cuena Boy R
    Rev Med Univ Navarra; 1984 Jun; 28(2):53-8. PubMed ID: 6149611
    [No Abstract]   [Full Text] [Related]  

  • 49. Medical treatment of peptic ulcer disease.
    Andersen BN
    Acta Chir Scand Suppl; 1988; 547():88-92. PubMed ID: 2906493
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Financial cost of the treatment of peptic ulcer].
    Castro Lde P; de Souza ZP; Ribeiro Tde C; Coelho LG; Avelar CD
    AMB Rev Assoc Med Bras; 1986; 32(1-2):21-4. PubMed ID: 2878471
    [No Abstract]   [Full Text] [Related]  

  • 51. Your CE topic this month (No. 9). Peptic ulcer disease.
    Perentesis GP; Kirschenbaum HL; Piltz GW
    J Pract Nurs; 1983; 33(8):35-43. PubMed ID: 6140312
    [No Abstract]   [Full Text] [Related]  

  • 52. [Conservative treatment of uncomplicated peptic ulcer by various methods].
    Sülle C; Murasko V; Balalükin A; Maljarova L; Lapsina S; Zsuravlev A
    Orv Hetil; 1985 Mar; 126(13):757-61. PubMed ID: 2859568
    [No Abstract]   [Full Text] [Related]  

  • 53. Cimetidine: a reivew of clinical trials.
    Cipolle RJ; Navarro RP; Fischer RP
    Minn Med; 1977 Jun; 60(5):446-9. PubMed ID: 17064
    [No Abstract]   [Full Text] [Related]  

  • 54. [Randomized double-blind placebo-controlled study of drugs with anti-ulcer action and their use in associated pathology].
    Ivashkin VT; Minasian GA
    Ter Arkh; 1988; 60(1):78-83. PubMed ID: 3129806
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Antisecretory therapy as a component of hemostasis in acute gastroduodenal ulcer bleedings].
    Gostishchev VK; Evseev MA
    Khirurgiia (Mosk); 2005; (8):52-7. PubMed ID: 16091681
    [TBL] [Abstract][Full Text] [Related]  

  • 56. H2-receptor antagonists.
    Nurs Times; 2004 Nov 2-8; 100(44):33. PubMed ID: 15552489
    [No Abstract]   [Full Text] [Related]  

  • 57. [Drug therapy and therapeutic tactics in gastroduodenal ulcer].
    Grigor'ev PIa; Isakov VA; Iakovenko EP
    Ter Arkh; 1988; 60(8):118-26. PubMed ID: 2906485
    [No Abstract]   [Full Text] [Related]  

  • 58. [Surgery of peptic ulcer 10 years after the introduction of anti-H2 agents].
    Bartolotta M; Carditello A
    Ann Gastroenterol Hepatol (Paris); 1988; 24(3):107-9. PubMed ID: 2899990
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Effect of M-cholinolytics and histamine H2 receptor blockaders on the acid-peptide factor in patients with peptic ulcer].
    Masevich TsG; Shastina NN
    Klin Med (Mosk); 1987 Oct; 65(10):73-6. PubMed ID: 2892966
    [No Abstract]   [Full Text] [Related]  

  • 60. [Current trends in medical therapy of gastroduodenal ulcer].
    Grassi M; Fraioli A; Messina B
    Clin Ter; 1987 Dec; 123(6):475-86. PubMed ID: 2902954
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.